Published in Dig Dis Sci on April 01, 2002
Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol (2009) 1.17
Helicobacter pylori infection and diabetes: is it a myth or fact? World J Gastroenterol (2014) 1.08
Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study. Int J Diabetes Dev Ctries (2010) 0.96
Stomach bugs and diabetes: an astounding observation or just confounding? Diabetes Care (2012) 0.92
Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol (2014) 0.89
Is Helicobacter pylori infection associated with glycemic control in diabetics? World J Gastroenterol (2015) 0.87
Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis. Diabetol Metab Syndr (2011) 0.84
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial. World J Gastroenterol (2006) 0.75
A patient with impaired gastric motility. Gut (2007) 0.75
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med (1998) 4.99
Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. Gut (1983) 2.83
Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care (2001) 2.60
Disordered gastric motor function in diabetes mellitus. Diabetologia (1994) 2.07
Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98
High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci (1996) 1.78
Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med (1991) 1.78
Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol (1994) 1.59
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol (1987) 1.19
Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol (1998) 1.16
Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol (1995) 1.08
Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol (2000) 1.04
Diabetes mellitus and Helicobacter pylori infection. Nutrition (2000) 1.03
Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol (2001) 1.03
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. Arch Intern Med (1998) 1.01
Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med (1995) 1.01
Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.00
Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis (1990) 0.97
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97
Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis (2001) 0.96
Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med (1996) 0.95
Helicobacter pylori associated gastric pathology in patients with type II diabetes mellitus and its relationship with gastric emptying: the Ankara study. Exp Clin Endocrinol Diabetes (1999) 0.92
Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci (1989) 0.90
Helicobacter pylori infection and gastric emptying of indigestible solids in patients with dysmotility-like dyspepsia. Scand J Gastroenterol (1997) 0.89
Does Helicobacter pylori-induced gastritis enhance food-stimulated insulin release? Dig Dis Sci (1996) 0.89
Rapid gastric emptying of a liquid meal in long-term Type 2 diabetes mellitus. Diabet Med (1998) 0.88
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract (2001) 0.87
The effect of Helicobacter pylori infection on gastric emptying of digestible and indigestible solids in patients with nonulcer dyspepsia. Am J Gastroenterol (1996) 0.87
Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1999) 0.86
Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol (1999) 0.84
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scand J Gastroenterol (2000) 0.84
High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis (2000) 0.82
Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care (1987) 0.81
The prevalence of Helicobacter pylori infection and types of gastritis in diabetic patients. The Kraków Study. Exp Clin Endocrinol Diabetes (1996) 0.79
Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci (1998) 0.79
Blood glucose concentration influences postprandial fullness in IDDM. Diabetes Care (1997) 0.79
The relationship between Helicobacter pylori infection and gastric emptying in patients with non-insulin-dependent diabetes mellitus. Eur J Nucl Med (1995) 0.79
Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. Diabetes Res Clin Pract (1996) 0.78
Gastroparesis of digestible and indigestible solids in patients with insulin-dependent diabetes mellitus or functional dyspepsia. Dig Dis Sci (1994) 0.76
Gastric emptying rate and hormonal response in type II diabetics. Diabetes Res (1991) 0.75
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A (2008) 4.67
Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol (2007) 4.14
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2011) 3.97
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Functional Dyspepsia. N Engl J Med (2015) 3.66
Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11
Gastro-oesophageal reflux disease. Lancet (2006) 2.96
A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med (2006) 2.94
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA (2008) 2.89
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol (2003) 2.83
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology (2004) 2.59
Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol (2005) 2.56
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology (2006) 2.46
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med (2002) 2.29
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol (2006) 2.21
Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab (2006) 2.20
Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology (2009) 2.19
Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies. Am J Gastroenterol (2013) 2.18
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care (2009) 2.08
Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04
Risks of proton-pump inhibitors: what every doctor should know. Med J Aust (2009) 2.03
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
Does Helicobacter pylori really cause duodenal ulcers? Yes. BMJ (2009) 2.01
Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res (2008) 2.00
Prevalence of faecal incontinence and associated risk factors; an underdiagnosed problem in the Australian community? Med J Aust (2002) 2.00
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept (2008) 1.97
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology (2002) 1.94
Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92
Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol (2009) 1.91
The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol (2005) 1.90
Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol (2009) 1.88
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86
Systematic review on the management of chronic constipation in North America. Am J Gastroenterol (2005) 1.85
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol (2005) 1.84
Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol (2004) 1.80
Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol (2008) 1.78
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med (2004) 1.72
Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia. Crit Care Med (2010) 1.70
Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol (2002) 1.70
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 1.67
Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol (2010) 1.65
Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol (2006) 1.64
Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. Am J Clin Nutr (2012) 1.64
Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol (2007) 1.63
Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol (2005) 1.63
Phenotypic characterization of taste cells of the mouse small intestine. Am J Physiol Gastrointest Liver Physiol (2007) 1.63
Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol (2012) 1.62
The effects of critical illness on intestinal glucose sensing, transporters, and absorption. Crit Care Med (2014) 1.60
Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol (2011) 1.60
American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology (2005) 1.60
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Seasonal change in osteoid thickness and mineralization lag time in ambulant patients. J Bone Miner Res (2007) 1.57
The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients. Crit Care Med (2008) 1.55
Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc (2008) 1.55
Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract (2011) 1.55
Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects. Br J Nutr (2010) 1.54
Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol (2007) 1.54
Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations. Crit Care Med (2007) 1.53
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med (2009) 1.53
GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol (2002) 1.53
Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition (2008) 1.52
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) (2005) 1.52
Can the clinical history distinguish between organic and functional dyspepsia? JAMA (2006) 1.51
Altered arterial homeostasis and cerebral aneurysms: a review of the literature and justification for a search of molecular biomarkers. Neurosurgery (2004) 1.51
5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol (2010) 1.50
Free fatty acids have more potent effects on gastric emptying, gut hormones, and appetite than triacylglycerides. Gastroenterology (2007) 1.49
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia. Diabetes (2013) 1.49
A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol (2009) 1.47